H.C. Wainwright analyst Raghuram Selvaraju raised the firm’s price target on ChromaDex (CDXC) to $11 from $8 and keeps a Buy rating on the shares. The company reported a modest sales beat and “impressive” earnings outperformance with multiple revenue accelerants, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDXC:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue